SCHEMBL16746015

SCHEMBL16746015

CC1CCCC(O)C(P(=O)(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.50
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
GAA P10253 1/20 0.40
LMNA P02545 3/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
SLC18A3 Q16572 2/20 0.34
RAB9A P51151 3/20 0.33
CNR1 P21554 2/20 0.33
CNR2 P34972 2/20 0.33
NPC1 O15118 2/20 0.33
ACHE P22303 1/20 0.33
MAPK1 P28482 1/20 0.33
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32
CA5A P35218 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26014617 1.00 KCNA5 (0.50) KCNA5CYP3A4CYP2C19SMN1; SMN2GAA
SCHEMBL26014606 1.00 KCNA5 (0.50) KCNA5CYP3A4CYP2C19SMN1; SMN2GAA
SCHEMBL26014619 0.94 KCNA5 (0.50) KCNA5CYP3A4CYP2C19SMN1; SMN2GAA
SCHEMBL26014618 0.94 KCNA5 (0.50) KCNA5CYP3A4CYP2C19SMN1; SMN2GAA
SCHEMBL5175578 0.84 SMN1; SMN2 (0.46) KCNA5SMN1; SMN2GAAMEN1KMT2A
SCHEMBL10719115 0.84 KCNA5 (0.45) KCNA5SMN1; SMN2GAAMEN1KMT2A
SCHEMBL16746019 0.74 GAA (0.35) KCNA5SMN1; SMN2GAASLC18A3
SCHEMBL22375302 0.74 GAA (0.35) KCNA5SMN1; SMN2GAASLC18A3
SCHEMBL22375301 0.74 GAA (0.35) KCNA5SMN1; SMN2GAASLC18A3
SCHEMBL16746020 0.74 GAA (0.35) KCNA5SMN1; SMN2GAASLC18A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230340013-A1 POLYPEPTIDES AND METHODS UNITED KINGDOM RESEARCH AND INNOVATION (GB) 2023-10-26 US disclosed
US-11732001-B2 Methods of incorporating an amino acid comprising a BCN group into a polypeptide using an orthogonal codon encoding it and an orthogonal pylrs synthase UNITED KINGDOM RESEARCH AND INNOVATION (GB) 2023-08-22 US disclosed
US-20150148525-A1 METHODS OF INCORPORATING AN AMINO ACID COMPRISING A BCN GROUP INTO A POLYPEPTIDE USING AN ORTHOGONAL CODON ENCODING IT AND AN ORTHORGONAL PYLRS SYNTHASE UNITED KINGDOM RESEARCH AND INNOVATION (GB) 2015-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230340013-A1 POLYPEPTIDES AND METHODS BCAT1, BCDIN3D, NPY1R KCNA5 3816/4885CYP3A4 3531/4885CYP2C19 3314/4885
US-11732001-B2 Methods of incorporating an amino acid comprising a BCN group into a polypeptide using an orthogonal codon encoding it and an orthogonal pylrs synthase COASY, BCAT1, FARSA KCNA5 4256/4885CYP3A4 3454/4885CYP2C19 2631/4885
US-20150148525-A1 METHODS OF INCORPORATING AN AMINO ACID COMPRISING A BCN GROUP INTO A POLYPEPTIDE USING AN ORTHOGONAL CODON ENCODING IT AND AN ORTHORGONAL PYLRS SYNTHASE BCAT1, BCDIN3D, YARS1 KCNA5 3641/4885CYP3A4 3496/4885CYP2C19 2654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.